HB 1809Session 2026
establishing a medical psilocybin advisory board to assess the advantages and disadvantages of the use of psilocybin for therapeutic purposes.
Progress
- Introduced
- In committee
- Passed House
- Passed legislature Not yet
- Sent to governor Not yet
- Became law Not yet
Legislative history
-
Senate
Inexpedient to Legislate, MA, VV === BILL KILLED ===; 05/07/2026; SJ 11
-
Senate
Committee Report: Inexpedient to Legislate, 05/07/2026, Vote 4-0, CC; SC 17
-
Senate
Hearing: 04/08/2026, Room 100, SH, 09:45 am; SC 13
-
Senate
Introduced 03/26/2026 and Referred to Health and Human Services; SJ 7
-
House
Ought to Pass with Amendment 2026-1201h: MA VV 03/26/2026 HJ 9 P. 43
-
House
Amendment # 2026-1201h (NT): AA DV 248-101 03/26/2026 HJ 9 P. 42
-
House
Inexpedient to Legislate: MF DV 127-222 03/26/2026 HJ 9 P. 42
-
House
Minority Committee Report: Ought to Pass with Amendment # 2026-1201h (NT)
-
House
Majority Committee Report: Inexpedient to Legislate 03/17/2026 (Vote 13-11; RC)
-
House
Executive Session: 03/17/2026 10:00 am GP 230
-
House
Division III Work Session: 03/13/2026 09:00 am GP 234
-
House
Referred to Finance 02/12/2026 HJ 4 P. 7
-
House
Ought to Pass: MA VV 02/12/2026 HJ 4 P. 7
-
House
Committee Report: Ought to Pass 01/28/2026 (Vote 18-0; CC) HC 6 P. 7
-
House
Executive Session: 01/28/2026 02:30 pm GP 158
-
House
Public Hearing: 01/14/2026 03:00 pm GP 158
-
House
Introduced 01/07/2026 and referred to Health, Human Services and Elderly Affairs HJ 1 P. 37